New developments on the role of NMDA receptors in Alzheimer's disease

被引：100
|
作者：
Malinow, Roberto [1 ,2 ]
机构：
[1] Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Neural Circuits & Behav, Div Biol, La Jolla, CA 92093 USA
来源：
CURRENT OPINION IN NEUROBIOLOGY | 2012年 / 22卷 / 03期
关键词：
AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; DENDRITIC SPINE LOSS; IN-VIVO; BETA PROTEIN; SYNAPTIC PLASTICITY; MOUSE MODELS; SIGNALING PATHWAY; TRANSGENIC MICE; OLIGOMERS;
D O I：
10.1016/j.conb.2011.09.001
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Since the initial findings that NMDA receptors play important roles in cellular models of learning as well as neurotoxicity, abnormal function of this receptor has been considered a potential mechanism in the pathophysiology underlying Alzheimer's disease. Treatment of Alzheimer's disease with an NMDA receptor antagonist began several years ago, with some limited success. More recent mechanistic studies have examined the role of NMDA receptors in the synaptic effects of beta amyloid (A beta).
引用
收藏
页码：559 / 563
页数：5
相关论文
共 50 条
  • [31] New developments in animal models of Alzheimer's disease.
    Janus C.
    Phinney A.L.
    Chishti M.A.
    Westaway D.
    Current Neurology and Neuroscience Reports, 2001, 1 (5) : 451 - 457
  • [32] New Developments of Clinical Trial in Immunotherapy for Alzheimer's Disease
    Yang, Cece
    Xiao, Shifu
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2015, 16 (06) : 484 - 491
  • [33] Central Role of Glucocorticoid Receptors in Alzheimer's Disease and Depression
    Canet, Geoffrey
    Chevallier, Nathalie
    Zussy, Charleine
    Desrumaux, Catherine
    Givalois, Laurent
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [34] The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer's Disease
    Abd-Elrahman, Khaled S.
    Sarasija, Shaarika
    Ferguson, Stephen S. G.
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (02) : 273 - 283
  • [35] Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease
    Makhaeva, Galina F.
    Lushchekina, Sofya V.
    Boltneva, Natalia P.
    Sokolov, Vladimir B.
    Grigoriev, Vladimir V.
    Serebryakova, Olga G.
    Vikhareva, Ekaterina A.
    Aksinenko, Alexey Yu.
    Barreto, George E.
    Aliev, Gjumrakch
    Bachurin, Sergey O.
    SCIENTIFIC REPORTS, 2015, 5
  • [36] Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease
    Galina F. Makhaeva
    Sofya V. Lushchekina
    Natalia P. Boltneva
    Vladimir B. Sokolov
    Vladimir V. Grigoriev
    Olga G. Serebryakova
    Ekaterina A. Vikhareva
    Alexey Yu. Aksinenko
    George E. Barreto
    Gjumrakch Aliev
    Sergey O. Bachurin
    Scientific Reports, 5
  • [37] NMDA receptor dysfunction in Alzheimer's disease
    Hynd, MR
    Scott, HL
    Dodd, PR
    JOURNAL OF NEUROCHEMISTRY, 2004, 88 : 50 - 50
  • [38] NMDA receptor dysfunction in Alzheimer's disease
    Hynd, MR
    Scott, HL
    Dodd, PR
    JOURNAL OF NEUROCHEMISTRY, 2003, 87 : 108 - 108
  • [39] Developments and trends in Alzheimer's disease
    Wilkinson, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 848 - 848
  • [40] Estrogen Receptors: A New Frontier in Alzheimer's Disease Therapy
    Cipriano, Giovanni Luca
    Mazzon, Emanuela
    Anchesi, Ivan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
12345